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Transcription factors of the POU family govern cell fate through combinatorial interactions with coactiva-
tors and corepressors. The POU factor Oct-3/4 can define differentiation, dedifferentation, or self-renewal of
pluripotent embryonic stem (ES) cells in a sensitive, dose-dependent manner (H. Niwa, J.-I. Miyazali, and A. G.
Smith, Nat. Genet. 24:372–376, 2000). Here we have developed a complementation assay based on the ability
of Oct-3/4 transgenes to rescue self-renewal in conditionally null ES cells and used this to define which domains
of Oct-3/4 are required to sustain the undifferentiated stem cell phenotype. Surprisingly, we found that
molecules lacking either the N-terminal or C-terminal transactivation domain, though not both, can effectively
replace full-length Oct-3/4. Furthermore, a fusion of the heterologous transactivation domain of Oct-2 to the
Oct-3/4 POU domain can also sustain self-renewal. Thus, the unique function of Oct-3/4 in ES cell propagation
resides in combination of the specific POU domain with a generic proline-rich transactivation domain.
Interestingly, however, Oct-3/4 target gene expression elicited by the N- and C-terminal transactivation
domains is not identical, indicating that at least one class of genes activated by Oct-3/4 is not required for ES
cell propagation.
Transcription factors regulate expression of specific genes to
control cellular phenotype. This is achieved via binding to
target DNA sequences, followed by interaction in cis with
components of the basal transcriptional machinery. These two
capacities are often separated into structurally and functionally
distinct DNA-binding and regulatory domains. The DNA-
binding domain provides for nucleotide sequence-directed lo-
calization to target genes. The regulatory domain(s) interacts
with one or more components of the basal transcription com-
plex, either directly or indirectly via bridging cofactors, to me-
diate activation or repression of gene expression (23, 34).
A regulatory domain that can activate expression is desig-
nated a transactivation domain. Many transactivation domains
have been identified in various transcription factors and are
grouped into five different classes based on their characteristic
amino acid composition: (i) acidic, (ii) glutamine-rich, (iii)
proline-rich, (iv) serine/threonine-rich, and (v) unclassified
(23, 46). The activities of transactivation domains are com-
monly defined in artificial systems based on transient transfec-
tion of a transcription factor plus reporter construct into het-
erologous cells. Although such systems have detected activities
of all classes of transactivation domains and revealed different
specificities (46), it is difficult to establish physiological distinc-
tions by this method.
The POU family transcription factor Oct-3/4 (also termed
Oct-3 or Oct-4, encoded by Pou5f1) (31, 36, 44) is expressed in
totipotent and pluripotent cells, including oocytes, early-cleav-
age-stage embryos, the inner cell mass (ICM) of the blastocyst,
epiblast, and germ cells (32, 42). Oct-3/4 is also present in
cultured pluripotent embryonic stem (ES) cells, embryonal
carcinoma cells, and embryonic germ cells (18, 43, 56) but is
absent from all differentiated somatic cell types in vitro and in
vivo.
The essential role of this transcription factor in mouse de-
velopment has been revealed by targeted gene deletion. Oct-
3/4-deficient embryos fail to initiate fetal development because
the prospective founder cells of the ICM do not acquire plu-
ripotency and become diverted into the extraembryonic tro-
phectoderm lineage (25). Further investigation via conditional
repression and expression in ES cells revealed that the precise
level of Oct-3/4 governs developmental fate. ES cells require a
critical level of Oct-3/4 to maintain their stem cell character
and pluripotency. A less than twofold increase causes differ-
entiation into endoderm and mesoderm, whereas reduction to
less than 50% of the normal expression level triggers dediffer-
entiation into trophectoderm (29). These results accord with
observations of subtle differences of Oct-3/4 levels in different
cell types in the early mouse embryo (32). Therefore, Oct-3/4
can be regarded as a candidate master regulator for initiation,
maintenance, and differentiation of pluripotent cells (27).
Oct-3/4 consists of the bipartite DNA-binding POU domain
that is diagnostic of POU family members and has both amino-
terminal (N-TD) and carboxy-terminal (C-TD) transactivation
domains (16, 31, 55). The N-TD is classified as a proline-rich
transactivation domain. The C-TD is a serine/threonine-rich
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transactivation domain, though it also has a high proline con-
tent. Several reports have provided evidence for a distinction
between N-TD and C-TD activity in heterologous transfection
assays (2, 6, 7, 16, 55). It remains unclear whether the two
transactivation domains have separate specificities that are sig-
nificant for the physiological functions of Oct-3/4.
In this report, we have analyzed the capacity of variant forms
of Oct-3/4 to sustain ES cell identity. Since the study was
carried out in the cellular context in which Oct-3/4 normally
operates, the results should reflect the relevant physiological
contribution of each domain.
MATERIALS AND METHODS
Cell culture and transfection. All ES cells were cultured in the absence of
feeder cells in Glasgow minimal essential medium (GMEM; Sigma, St. Louis,
Mo.) supplemented with 10% fetal calf serum (Biowhittaker, Walkersville, Md.),
1 mM sodium pyruvate, 104 M 2-mercaptoethanol, 1 nonessential amino
acids, and 1,000 U of leukemia inhibitory factor (LIF) per ml on gelatin-coated
dishes (48). In the rescue experiments, 107 ZHBTc4 ES cells (29) were electro-
porated with 50 g of linearized plasmid DNA at 800 V and 3 F in a 0.4-cm
cuvette using a Gene Pulser (Bio-Rad, Hercules, Calif.), followed by culture with
or without 1 g of tetracycline (Tc) per ml for 2 days. Then these cells were
cultured in the presence of 1 g of puromycin per ml with or without Tc for 7
days. Under this condition, single-copy integration of the vector DNA into the
host genome can be achieved in 80% of drug-resistant colonies. The resulting
stem cell colonies were scored by staining with Leishman stain or pooled as the
stable transfectants for preparing RNA and protein samples and for transfection
of reporter constructs.
For the selection of high expressers, transfectants were cultured in the pres-
ence of 9 g of puromycin per ml in the first 3 days. For supertransfection of
episomal vectors, 5  104 MG 1.19 ES cells (13) were transfected with 2 g of
supercoiled plasmid DNA using Lipofectamine 2000 (Invitrogen, Groningen,
The Netherlands), and then replated and cultured in the presence of 1 g of
puromycin per ml for 8 days. This method allows efficient production of stable
transfectants, reaching 50% of treated cells, so differentiation events induced by
overexpression of transgenes can be easily confirmed by morphology of primary
transfectants (28, 29). EB3 is a germ line-competent ES cell line derived from
E14tg2a and has one allele of Pou5f1 inactivated by targeted integration of an
IRESBSDpA cassette (H. Niwa, unpublished).
BMT-10 cells (14) were cultured in GMEM supplemented with 10% fetal calf
serum. For transient transfection, 105 BMT10 cells were transfected with 4 g of
supercoiled plasmid DNA using Lipofectamine 2000.
Construction of expression vectors and reporter plasmids. The pacbGHpA
cassette from pPGKpurobGHpA (54) was amplified by PCR with oligonucleo-
tide primers 5-AAGCTTATCATGACCGAGTACAAGC-3 and 5-GAGCCC
CTGCAGGTTCTTTCCGCC-3 using Pfu polymerase (Promega, Madison,
Wis.). The product was digested with BspHI and PstI and ligated to the PstI-NotI
backbone and the NotI-NcoI internal ribosome entry site (IRES) fragments of
pCAG-IZ (28) to give pCAG-IP. cDNAs were introduced between the XhoI and
NotI or BstXI sites of pCAG-IP.
To construct the mutant Oct-3/4 expression vectors, the full-length cDNA of
mouse Oct-3/4 subcloned between the HincII and SmaI sites of pBluescript
KS() (Stratagene, La Jolla, Calif.), designated pBl-Oct-3/4, was used as a
template for PCR amplification using high-fidelity KOD (Toyobo, Osaka, Japan)
or Pfx (Invitrogen, Groningen, The Netherlands) DNA polymerase. Wild-type,
N, C, NC, 2-62, and 2-62C Oct-3/4 fragments were generated with the
appropriate primer pairs listed in Table 1 following introduction of the resulting
PCR product into BstXI sites of pCAG-IP with BstXI adapters (5-GGCCGCA
CTGGCCACA-3 and 5-GCCAGTGCGGCC-3).
An in-frame hemagglutinin (HA) epitope was introduced by insertion of
double-stranded oligonucleotides shown in Table 1 encoding the HA epitope
(YPYDVPDYA) (11) into the NcoI site overlapping the start codon by the
partial fill-in method. A point mutation in amino acid 267, valine to proline
(267V/P), was introduced into pBl-Oct-3/4 using the pairwise primers in Table 1.
To put the Oct-3/4 N-TD or Oct-2 C-TD flanking the C terminus of the Oct-3/4
POU domain, the indicated region was amplified with the appropriate primer
pairs listed in Table 1 and plasmid pBl-Oct-3/4 or pOEV1 (24) as a template. To
construct the enhanced green fluorescent protein (EGFP) fusion expression
vector, pEGFP (Clonetech, Palo Alto, Calif.) was used as a template for PCR
with the pairwise primers in Table 1, and the resulting product was introduced
into the wild-type, N, or NC expression vector.
Luciferase reporter plasmids were constructed by introduction of the regula-
tory elements listed in Table 2 into pGL3-Basic (Promega, Madison, Wis.).
Luciferase reporter assay. For the luciferase reporter assay in ES cells, 2 g of
supercoiled DNA of reporter plasmids was cotransfected into 3  104 cells with
0.02 g of pRL-CMV (Promega, Madison, Wis.) using Lipofectoamine 2000.
Two days after transfection, luciferase activities were measured by the dual
luciferase assay system (Promega, Madison, Wis.).
RNA analysis. For Northern blot analysis, 4 g of total RNA was analyzed by
nonradioactive filter hybridization (Gene Image; Amersham Pharmacia, Buck-
inghamshire, United Kingdom) with Oct-3/4, Sox2, Fgf4, Utf1, Zfp42/Rex1, Upp,
Ebaf/Lefty1, Otx1, 226/Tera, and Gap cDNA probes.
EMSA analysis. Nuclear extracts were prepared from ZHBTc4 ES cells and
their derivatives as described by Schreiber et al. (45). Electrophoretic mobility
shift assays (EMSAs) were performed with the DIG gel shift kit (Roche, Basel,
Switzerland) per the manufacturer’s protocol using the digoxigenin (DIG)-la-
beled double-stranded oligonucleotide containing the typical octamer binding
TABLE 1. Oligonucleotides used for generating Oct-3/4 mutantsa
Category and primer Position Sequence
Mouse Oct-3/4
wt forward 39–60 5-CCACCTTCCCCATGGCTGGACA-3
wt reverse 1101–1120 5-AGGGCTGGTGCCTCAGTTTG-3
N forward 435–454 5-ACCTTCCCCATGGCCCAGGACATGAAAGCCCTG-3
C reverse 875–895 5-AGTTAACTTGATCTTTTGCCCTTCTG-3
1-62 forward 236–254 5-ACCTTCCCCATGGAGTTCTGCGGAGGGATGG-3
1-62 reverse 217–235 5-AAATGCATGTATGCGGGCGGACATGGG-3
267V/P forward 845–871 5-GTGCCCCGGGTATGGTTCTGTAACCGG-3










a In primers for mouse Oct-3/4, the underlined bases indicate mismatches, and positions are shown based on the reported cDNA sequence (GenBank no. M34381),
which contains one base deletion of G at position 934, and the correct sequence results in a length of 1,325 bp.
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site (ATGCAAAT) attached as a control oligonucleotide in this kit, and with the
indodicarbocyanine (Cy5)-labeled double-stranded oligonucleotide with the
same sequence as above followed by the detection of fluorescent signal using a
Fluorimager (Typhoon 8600; Amersham Pharmacia, Buckinghamshire, United
Kingdom).
Immunoblotting. Ten-microliter aliquots of nuclear extracts or whole-cell ly-
sates with radioimmunoprecipitation assay buffer were fractionated on a sodium
dodecyl sulfate SDS–10% polyacrylamide gel and electroblotted onto a polyvi-
nylidene difluoride membrane (Immobilon; Nihon Millipore, Yonezawa, Japan).
After treatment in blocking buffer (1 TTBS [10 mM Tris HCl {pH 7.4}, 137
mM NaCl, 2.7 mM KCl, 0.1% Tween 20] plus 3% skimmed milk), membranes
were sequentially probed with the anti-HA (11) (clone 12CA5; Roche, Basel,
Switzerland), anti-Oct3/4N (47) (provided by H. Hamada), or anti-EGFP (MBL,
Nagoya, Japan) and then horseradish peroxidase-coupled anti-mouse immuno-
globulin G (IgG) or anti-rabbit IgG (Zymed Laboratories, South San Francisco,
Calif.), and developed using ECL reagents (Amersham Pharmacia, Buckingham-
shire, United Kingdom).
RESULTS
ES cell-based complementation assay for Oct-3/4 function.
We have previously described how conditional repression of
Oct-3/4 in ES cells using the Tc regulatory system (15) induces
dedifferentiation into the trophectoderm lineage (29). ZHBTc4
ES cells harbor the Tc-dependent transactivator Oct-3/4 trans-
gene and have had both endogenous alleles of Oct-3/4 inacti-
vated by gene targeting. These cells can be propagated as ES
cells in the absence of Tc, in which condition the Oct-3/4
transgene is active, but not in the presence of Tc, which re-
presses the transgene. We reasoned that this system could
provide a complementation assay to delineate which elements
of Oct-3/4 are required to sustain ES cell identity. The basis of
the assay is suppression of dedifferentiation and formation of
ES cell colonies in the presence of Tc.
To test this approach, the wild-type Oct-3/4 cDNA under the
control of the constitutive CAG expression unit (30) was trans-
fected into ZHBTc4 ES cells (Fig. 1A). ES cell colonies were
obtained in the presence of Tc, whereas no stem cell colonies
were produced in untransfected controls (without selection) or
after transfection of the empty expression vector (Fig. 1B and
Table 3). This result indicates that the stem cell phenotype can
be rescued by the appropriate level of expression of Oct-3/4
from an introduced transgene. The rescue event was substan-
tiated by Northern hybridization analysis. Expression of the
Oct-3/4-IRES-pac transgene was evident, but neither the Tc-
regulatable Oct-3/4-IRES-geo nor any endogenous Oct-3/4
mRNAs were detected (Fig. 1C).
The rescued clones are expected to undergo differentiation
on induction of the Tc-regulatable Oct-3/4 transgene due to
overproduction of Oct-3/4 beyond the upper threshold level.
Consistent with this, transfer of rescued clones to culture me-
dium lacking Tc resulted in differentiation (Fig. 1B) in 40% of
colonies, in a manner identical to that observed for overex-
pression of Oct-3/4 in heterozygous ZHTc6 cells (29). Con-
versely, transfectants isolated in the absence of Tc are antici-
pated to express only low levels of the transgene. Indeed most
of these cells differentiated into trophectodermal phenotypes
on addition of Tc (data not shown), indicative of inadequate
levels of Oct-3/4.
To investigate the specificity of this rescue assay, constructs
for expression of other POU factors were introduced into the
ZHBTc4 cells. In contrast to Oct-3/4, expression of Oct-1,
Oct-2, or Oct-6 did not produce any stem cell colonies in the
presence of Tc (Table 3). Either Oct-1 or Oct-6 overexpression
gave fewer stem cell colonies in the absence of Tc, as we
observed in the episomal expression system (29) without in-
duction of differentiation, indicating that a moderate level of
overexpression of these POU factors still provides some
strange toxicity in ES cells. The Sry-related transcription factor
Sox2, which is a partner of Oct-3/4 (57) in activation of specific
genes such as fibroblast growth factor (Fgf-4) and Utf-1, also
cannot substitute for Oct-3/4 function in ZHBTc4 ES cells.
These results confirm the specific requirement for Oct-3/4
function to maintain the undifferentiated self-renewing pheno-
type of ES cells.
DNA-binding ability is essential for maintaining stem cell
renewal. Oct-3/4 contains three functionally characterized do-
mains, the transcriptional activation domains N-TD and C-TD
and the POU DNA-binding domain. First, we tested whether
DNA binding by Oct-3/4 was required to maintain stem cell
renewal. We inactivated Oct-3/4 DNA binding by changing a
single amino acid (Val267 to Pro) in the recognition helix of
the POU homeodomain (HA267V/P) (55). The mutated pro-
tein was efficiently produced in transiently transfected cells
and, as expected, showed dramatically reduced binding to the
octamer DNA probe (Fig. 2B). When the mutant Oct-3/4 ex-
pression vector was introduced into ZHBTc4 ES cells, it could
not rescue stem cell renewal in the presence of Tc (Fig. 2A)
although stable production of the HA-tagged mutant protein
was confirmed by Western blot analysis of transfectants iso-
lated in the presence of Tc (Fig. 2C). These data indicate that
the high-affinity DNA-binding ability of Oct-3/4 is essential for
its proper function in ES cells.
Functional assay of N- and C-terminal regions. As the next
step, Oct-3/4 deletion mutants lacking either N-terminal amino
acids (aa) 3 to 129 (N), C-terminal aa 283 to 352 (C), or
both (NC) were generated, and their ability to rescue stem
cell renewal was assayed. Transfection with the NC (POU
domain only) mutant resulted in differentiated cells and no
stem cell colonies. However, both N and C mutants yielded
high numbers of undifferentiated ES cell colonies (Fig. 3A).
TABLE 2. Regulatory elements used for generating luciferase
reporter plasmids
Element Origin
PGK 507-bp EcoRI-TaqI fragment containing mouse
phosphoglycerate kinase (PGK-1) promoter (1)
tk 168-bp BamHI-XhoI fragment derived from
pBLCAT2 (19) containing herpes simplex
virus thymidine kinase (tk) promoter
6Wtk 6W enhancer containing 6 copies of
oligonucleotides with octamer-binding motif
from the mouse immunoglobulin heavy chain
gene enhancer (40) upstream of the tk
promoter
Fgf-4 5 460-bp PCR-amplified genomic DNA carrying
the Fgf-4 enhancer (57) placed upstream of
the tk-luc cassette in plasmid ptk-luc
Fgf-4 3 Fgf-4 enhancer placed downstream of the tk-luc
cassette in plasmid ptk-luc
052 9.5-kb mouse retrotransposon 052
enhancer/promoter (4)
Rex-1 PCR-amplified 307-bp mouse Zfp42/Rex1
promoter (3)
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The ES cell identity of rescued cells was established by the
following criteria: (i) characteristic colony morphology, (ii)
contact-independent proliferation, (iii) zeocin resistance, re-
flecting activity of the endogenous Oct-3/4 promoter carrying a
knock-in of zeo, (iv) expression of the Oct-3/4-independent
stem cell marker gene Sox2, and (v) differentiation on with-
drawal of LIF. The latter assay demonstrates that self-renewal
remains cytokine dependent and that the cells retain the ca-
pacity for differentiation.
This finding implied that, in combination with the POU
domain, either the N or the C terminus is sufficient to maintain
stem cell phenotype. The absence of wild-type Oct-3/4 protein
in the transfectants grown in the presence of Tc was confirmed
by immunoblotting with polyclonal anti-Oct3/4N antibody, rec-
ognizing the N terminus of Oct-3/4 (47) (Fig. 3B). EMSAs
revealed that the NC mutant protein is present in unres-
cued ZHBTc4 ES cells maintained in the absence of Tc and
that only the mutant proteins were present in the N- and
C-rescued ES cells (Fig. 3C).
The reduced level of expression of the NC mutant pro-
tein selected in normal conditions might be due to preparation
of nuclear lysate from unrescued ES cells (lane 4 in Fig. 3C), in
which there is no selection pressure in the expression level of
transgene to rescue ES self-renewal. Indeed, higher amounts
of the NC protein can be observed in nonrescued cells
selected with a high dose of puromycin (lane 5 in Fig. 3C).
These data suggest that the two separated transactivation do-
mains have equivalent functionality in ES self-renewal. This is
somewhat surprising given that they represent different classes
of transactivation domain (6), each with a relatively high de-
gree of conservation of characteristic amino acid composition,
and that assays in heterologous cells have pointed to distinc-
tions in activity (see Discussion).
POU domain alone is not sufficient for maintaining stem
cell renewal. The previous experiments suggested that the Oct-
3/4 POU domain alone is necessary but not sufficient to sup-
port stem cell renewal. However, since the expression level of
Oct-3/4 is critical for maintaining stem cell phenotype (29), it
FIG. 1. Oct-3/4 complementation assay. (A) Schematic of complementation assay system. ZHBTc4 ES cells (29) contain a Tc-regulated Oct-3/4
transgene and both alleles of endogenous Oct-3/4 have been inactivated by targeted integration of IRESzeopA and IRESBSDpA cassettes. The
Oct-3/4 transgene is repressed by addition of Tc, so stem cell colonies can form in the presence of Tc only when an introduced transgene in the
pCAG-IP vector can replicate the function of Oct-3/4 and sustain stem cell renewal. Abbreviations: BSD, Aspergillus blasticidin S deaminase; zeo,
zeocin resistance gene; IRES, encephalomyocarditis virus internal ribosome entry site; hph, hygromycin phosphotransferase; CAG, CAG expres-
sion unit; tTA, Tc-dependent transactivator; -geo, fusion gene between the Escherichia coli genes for -galactosidase and neomycin phospho-
transferase; pac, puromycin acetyltransferase; Ori, DNA replication origin. (B) Photomicrographs of ZHBTc4 ES cells cultured in the absence of
Tc (left upper, undifferentiated), ZHBTc4 cells cultured in the presence of Tc (right upper, differentiated), ZHBTc4 cells transfected with the
Oct3/4wt expression vector cultured in the presence of Tc (left lower, undifferentiated), and the rescued ZHBTc4 Oct-3/4wt transfectants
transferred to medium lacking Tc (right lower, differentiated). (C) Expression of Oct-3/4 transgenes in ZHBTc4 ES cells transfected with the
wild-type (wt) expression vector. ZHBTc4 cells maintained in the absence of Tc express full-length and truncated mRNAs derived from the
Oct-3/4geo transgene (29) and lack endogenous Oct-3/4 transcripts. Oct-3/4wt transfectants grown with Tc lack transcripts derived from the
Oct-3/4geo transgene and express the Oct-3/4IP transgene only. Oct-3/4wt transfectants grown without Tc express transcripts derived from both
transgenes. EB3 was maintained by the endogenous Oct-3/4.
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is necessary to examine nuclear protein in order to distinguish
between a true qualitative difference and a quantitative effect
arising from inappropriate intracellular localization or insta-
bility. For this purpose, we generated constructs in which the
EGFP coding sequence is fused in-frame to Oct-3/4 sequences.
N-terminal GFP fusions with full-length Oct-3/4 (EGFPwt)
or with N Oct-3/4 (EGFPN) could rescue stem cell renewal
efficiently when introduced into ZHBTc4 cells (Fig. 4A). Im-
munoblotting confirmed that these fusion proteins maintain
stem cell renewal in the absence of endogenous Oct-3/4 (Fig.
4B). However, an EGFP fusion with NC (EGFPNC) did
not generate any rescued stem cell colonies in the presence of
Tc (Fig. 4A), although a significant amount of the EGFPNC
mutant protein was expressed in transfectants (Fig. 4C). The
signal of EGFPNC might be weaker than the others be-
cause the nuclear extract was prepared from unrescued ES
cells, as mentioned above. By fluorescence microscopy, the
EGFP signals can be detected at similar intensity in the nuclei
of cells transfected with each of the EGFP fusion proteins (Fig.
4D).
We previously reported that maintenance of Oct-3/4 expres-
sion cannot prevent differentiation induced by withdrawal of
LIF (29). This finding was confirmed by removal of LIF from
ES cells rescued by the expression of EGFPwt. These cells
readily differentiated while retaining Oct-3/4 activity, as re-
vealed by EGFP fluorescence (Fig. 4D).
The subcellular localization of the EGFP fusions indicates
that the nuclear localization signal of Oct-3/4 is present in the
POU domain, as previously reported for Oct-6 (50). However,
the proper production and nuclear localization of EGFPNC
fusion protein confirm that the POU binding domain alone
lacks an essential function to maintain stem cell renewal.
Transactivation domain is required for stem cell renewal of
ES cells. Deletion of the entire N- or C-terminal sequence
suggested that the transactivation domains in these regions are
necessary for stem cell renewal. To test the requirement for
transactivation domains more precisely, we made various mu-
tant forms of Oct-3/4 and examined their function in our res-
cue system. A deletion of aa 2 to 62 of the minimal proline-rich
N-TD (aa 13 to 60) (16) in combination with the C truncation
abolished the ability to rescue stem cell renewal (HA2-62C
in Fig. 5). This confirms the requirement specifically for a
transactivation domain.
Interestingly, when aa 1 to 62 containing the N-TD was
transferred to the C terminus of the 2-62C mutant, the
resulting Oct-3/4 (HA2-62C1-62) rescued stem cell re-
newal. Therefore, the orientation of the transactivation do-
main relative to the POU domain is not critical. Moreover,
addition of these residues to the C terminus of the POU
domain only also yielded a version of Oct-3/4 (HANC1-
62) competent to support the propagation of ES cells (Fig. 5).
These data show that combination of the minimal N-TD with
the POU domain is sufficient to maintain stem cell self-renewal
in vitro.
Both N-TD and C-TD are proline-rich, although the latter is
also serine/threonine-rich. The similarity in amino acid com-
position might be the basis for their interchangeable role in
sustaining stem cell renewal. To test this idea, we assayed the
function of a heterologous transactivation domain. Oct-2 can-
not substitute for Oct-3/4 function in ES cells (Table 1). How-
ever, the transactivation domain at the C terminus of Oct-2
(Oct2CTD) is a well-characterized proline-rich transactivation
domain (52). We combined the Oct2CTD with the Oct-3/4
POU domain and introduced the resultant fusion (HA2-
62COct2CTD or HANCOct2CTD) into ZHBTc4 ES
cells. In contrast to full-length Oct-2, the chimeric molecule
could sustain the undifferentiated state (Fig. 5). This finding
indicates that the transactivation domains in Oct-3/4 do not
have any unique character in their function and can be re-
placed with other transactivation domains.
Gene expression in ES cells rescued by mutants. Pools of
colonies rescued by transfection of wild-type, N, or C Oct-
3/4 expression vectors were expanded in the presence of Tc for
further characterization. To interrogate the function of the
mutant Oct-3/4 proteins in these rescued ES cells, transcription
of seven Oct-3/4 target genes was examined by Northern blot
analysis (Fig. 6A). All seven genes are downregulated in Tc-
treated ZHBTc4 ES cells with kinetics parallel to the disap-
pearance of Oct-3/4 transcripts (29) (data not shown on Utf-1
and 226/Tera). Expression of six of the seven was restored in
the rescued ES cells. Expression of one gene, Ebaf/lefty1, how-
ever, was appreciable in cells rescued by full-length Oct-3/4
and C, but was barely detectable in ES cells rescued by N.
This result was consistent with three different RNA prepara-
tions. These data suggest either that N-TD possesses specific
activity to direct expression of Ebaf/Lefty1 or that C-TD spe-
cifically lacks this ability.
To distinguish these two possibilities, we next assayed Ebaf/
Lefty1 expression in ES cells rescued by other mutants. Normal
levels of Ebaf/Lefty1 expression were detected in ES cells res-
cued by HA2–62C1–62 and HA2–62COct2CTD.
The finding that Oct2CTD can substitute for N-TD and acti-
vate Ebaf/Lefty1 expression implies that the Oct-3/4 C-TD is
specifically deficient in this capacity.
Comparative analysis of transcriptional activation by mu-
tant Oct-3/4 proteins. To characterize further the difference
between N-TD and C-TD in activating particular target genes,
we employed luciferase reporter assays. Five constructs con-
taining transcriptional regulatory elements activated by Oct-
3/4 in ES cells were prepared (Table 3). They are known to be
activated in different manners by Oct-3/4 and cofactors, such as
TABLE 3. Generation of stem cell colonies of ZHBTc4 ES cells in
the presence and absence of Tc by transfection of 4 various
expression vectorsa
Gene
No. of stem cell colonies
per 107 treated cells Rescue index
(Tc/Tc)
Tc Tc
Oct-3/4 84 83 1.01
Oct-1 0 21 0
Oct-2 0 271 0
Oct-6 0 45 0
Sox2 0 138 0
None 0 321 0
a 107 ZHBTc4 ES cells were transfected with 50 g of linearlized vector DNAs
by electroporation. After 7 days of selection with puromycin in the presence or
absence of Tc, the number of stem cell colonies was scored. Rescue index 
number of stem cell colonies in the presence of Tc/number of stem cell colonies
in the absence of Tc.
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the Fgf-4 enhancer activated by Oct-3/4 and Sox2 (57), the 052
promoter and enhancer activated by Oct-3/4 and adenovirus
E1A (4, 47), the Rex1 promoter activated by Oct-3/4 and Rox1
(3), and 6Wtk activated by Oct-3/4 alone (41). For all reporter
plasmids, downregulation of the luciferase activity on repres-
sion of Oct-3/4 was confirmed by measuring luciferase activi-
ties in ZHBTc4 ES cells with or without Tc (Fig. 7A). When
transfected into rescued ES cells, each of these reporters was
activated by different Oct-3/4 variants to a similar extent, ex-
cept for the 6W construct (Fig. 7B). 6W luciferase activity in
the presence of C was comparable to that induced by full-
length Oct-3/4, and in both cases significantly greater than that
in the presence of N. N-TD is therefore required for full
transactivation in this instance. These data also suggested that
there is no cooperativity between N-TD and C-TD, because
reporter activities were comparable to those observed in wild-
type ES cells or ZHBTc4 cells rescued with Oct-3/4wt (Fig.
7B).
Induction of differentiation by overexpression of mutant
Oct-3/4 proteins. We previously showed that upregulation of
Oct-3/4 in ES cells provokes endodermal and mesodermal
differentiation. To investigate which part of Oct-3/4 is respon-
sible for this phenomenon, expression vectors carrying mutant
Oct3/4 transgenes were introduced into ES cells by episomal
supertransfection (13, 28). Supertransfection of full-length
Oct-3/4 produced many differentiated colonies to endoderm-
like cells as previously. All mutant expression vectors that
rescued stem cell renewal similarly generated differentiated
colonies (Fig. 8). In contrast, transfection with inactive NC,
EGFPNC, and HA2-62C constructs produced stem cell
colonies. Thus, the minimal combination of POU domain plus
transactivation domain is sufficient and necessary to induce
differentiation when overexpressed. Unexpectedly, however,
expression of the DNA-binding mutant HA267V/P blocked
self-renewal and generated differentiated colonies. Thus, Oct-
FIG. 2. Rescue of stem cell self-renewal by wild-type Oct-3/4 and
the 267V/P mutant lacking DNA-binding ability. (A) Diagram of wild-
type and mutant gene products. N-TD, C-TD, and the POU domain
are represented as boxes. The point mutation in the HA267V/P mutant
is positioned in the POU homeodomain. Both cDNAs have an in-
frame HA tag upstream of the start codon. Rescue index is scored as
in Table 3. (B) Western blot and EMSA analysis of nuclear extracts
prepared from BMT10 cells transfected with the HAwt or HA267V/P
expression vector. Production of comparable amounts of transgene
products was confirmed in each transfectant by immunoblotting with
anti-HA antibody (upper panel). EMSA analysis of the same nuclear
extracts with the DIG-labeled probe confirmed that HA267V/P binds
to octamer motif with much lower efficiency than Oct3/4wt (lower
panel). Equal loading of nuclear extracts was confirmed by the inten-
sity of shift bands corresponding to endogenous Oct-1. (C) Western
blot analysis of nuclear extracts prepared from the rescued and unres-
cued ES cells transfected with HAwt or HA267V/P. Similar amounts of
transgene product with HA tag were detected by anti-HA antibody.
FIG. 3. Rescue of stem cell renewal by deletion mutants. (A) Di-
agram of wild-type and mutant gene products. N and C lack aa 3 to
129 and 283 to 352, respectively, and NC consists of aa 130 to 282.
The rescue index was determined as in Table 3. (B) Western blot
analysis of nuclear extracts prepared from rescued transfectants with
wild-type, N, and C grown in the presence of Tc and unrescued
transfectants with NC grown in the absence of Tc with anti-Oct3/4N
antibody. The rescued cells with N or C lack wild-type Oct-3/4
protein. Mutant protein of C but not N and NC can be detected
by anti-Oct3/4N antibody. Two different sizes of bands are occasionally
detected with anti-Oct3/4N antibody. The upper band appears to rep-
resent the phosphorylated form, because this signal can be intensified
by preparation of nuclear extracts in the presence of phosphatase
inhibitors (PI). We always detected a single C band, because the
phosphorylation sites of Oct-3/4 are located in the C terminus (6, 35).
(C) EMSA analysis of nuclear extracts analyzed in panel B with the
Cy5-labeled probe. All mutants can bind to the octamer motif with
comparable intensity to the wild-type Oct-3/4. The signal for NC is
weaker in lane 4, but it expressed an amount comparable to the others
in unrescued cells selected with 9 g of puromycin per ml in lane 5.
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3/4 DNA-binding ability, which is required to sustain self-
renewal, is not essential to induce differentiation upon ele-
vated expression.
DISCUSSION
The mammalian fetus is generated from a pluripotent
founder population, the epiblast that develops in the blasto-
cyst. This pluripotent stage of development can be continu-
ously propagated in culture in the form of mouse ES cells (9,
20). The mechanisms by which pluripotency is established and
sustained remain obscure (33). However, it appears that the
POU factor Oct-3/4 plays a central role in both processes (27).
Oct-3/4 activity is essential for the initial formation of pluripo-
tent cells in the mouse blastocyst (25) and for their mainte-
nance in culture as ES cells (29). The present study was aimed
at clarifying the contribution of different functional domains of
Oct-3/4 protein to these effects. The findings demonstrate that
the POU domain of Oct-3/4 is uniquely required and, in com-
bination with a generic proline-rich transactivation domain, is
sufficient to maintain the undifferentiated stem cell phenotype.
Oct-3/4 possesses two separate transactivation domains that
have been reported to show distinct activities in different assay
systems. Imagawa et al. reported that they detected transacti-
vation ability only in the N terminus by an assay in which the
N and C termini of Oct-3/4 were fused to the c-Jun DNA-
binding domain and activity was tested in P19 EC cells using a
reporter construct with multiple c-Jun-binding sites (16). In
contrast, Vigano’ and Staudt identified both N-TD and C-TD
FIG. 4. Rescue of stem cell renewal by EGFP fusion constructs. (A) Diagram of EGFP fusion constructs with wild-type and mutant gene
products. The rescue index was determined as in Table 3. (B) Western blot analysis of nuclear extracts prepared from rescued transfectants with
EGFPwt and EGFPN grown in the presence of Tc and unrescued transfectants with EGFPNC grown in the absence of Tc. Anti-Oct3/4N
antibody detects wild-type Oct-3/4 in the latter but not the former, confirming the rescue events in EGFPwt and EGFPN transfectants.
(C) Western blot analysis of the blot used in panel B with anti-GFP antibody. Proper production of EGFP fusion proteins was confirmed.
(D) Photomicrographs of phase-contrast and fluorescent views of a stem cell colony rescued by the expression of EGFPwt (top) and of
nucleus-localized EGFPNC in a stem cell colony grown in the absence of Tc (bottom). Nuclear fluorescence from EGFPwt is retained in
differentiated cells produced after withdrawal of LIF (middle).
FIG. 5. Rescue of stem cell renewal by combination of the POU
domain with transactivation domains. Diagram of mutant gene prod-
ucts and the rescue index for them are shown. The rescue index was
determined as in Table 3.
1532 NIWA ET AL. MOL. CELL. BIOL.
activities by transactivation of a reporter plasmid containing six
copies of the octamer motif upstream of the -globin promoter
in HeLa cells. They found stronger activity from C-TD than
N-TD and also that an Oct-3/4 mutant unable to bind the
octamer target could activate transcription in an octamer-de-
pendent manner (55).
However, these heterologous assay systems may lead to mis-
reading of native function. Thus, Brehm et al. revealed that the
activity of C-TD is modulated in a cell type-dependent manner
(6). Oct-3/4 can directly activate transcription of target genes
when the cis binding site is positioned proximal to the pro-
moter (41). More commonly, however, Oct-3/4 appears to bind
to distal elements, in which case gene activation (or repression)
requires cooperation with other factors. Adenovirus E1A can
serve as a bridging factor between Oct-3/4 and the basal tran-
scription machinery and this function appears to be repro-
duced by a cellular factor(s) in pluripotent cells (41).
Several nuclear proteins seem to interact with Oct-3/4, in-
cluding high-mobility group and bromodomain proteins (8),
and the Sry-related transcription factor Sox2. The last partic-
ipates with Oct-3/4 in cooperative enhancer binding and syn-
ergistic transcriptional activation of the Fgf-4 (57) and Utf-1
genes (26). In reporter assays, the Oct-3/4 POU domain plus
N-TD is sufficient to stimulate transcription from the Fgf-4
enhancer in the absence of Sox2. The C-TD, in contrast, is
latent in this assay and becomes active only by cooperation
with Sox2, resulting in the synergistic enhancement of tran-
scription (2). Therefore, the activities of the two transactiva-
tion domains can be differentially affected by protein-protein
interaction.
In this study we have found that in the relevant physiological
context of ES cells, N-TD and C-TD function redundantly to
maintain self-renewal. We found that the presence of either
N-TD or C-TD was sufficient, provided the Oct-3/4 POU do-
main was intact. The requirement for a transactivation domain
demonstrates that the critical function of Oct-3/4 does involve
target gene activation and cannot be attributed entirely to gene
repression. The data indicate, however, that the two Oct-3/4
transactivation domains have overlapping specificity and that
neither makes a unique contribution to ES cell propagation.
Yet the activity of these two transactivation domains is not
identical in ES cells. Analysis of expression of Oct-3/4 target
genes revealed that Ebaf/Lefty1 expression is significantly re-
duced in ES cells rescued by the expression of the N mutant.
This mutant also failed to activate the 6Wtkluc reporter, which
can be activated by Oct-3/4 alone in HeLa cells (41). This
suggests that the N-TD has a specific function to transactivate
a suite of target genes independently of interaction with part-
ners such as Sox2 (57) or cellular E1A-like factors (41). How-
ever, it might be better to regard this phenomenon as mediated
by a specific defect of the C-TD to transactivate a particular
type of target promoter, because the Oct-2 C-TD possesses a
function similar to that of the N-TD. The data also imply that
expression of a subset of Oct-3/4 target genes represented by
Ebaf/Lefty-1 is not necessary for self-renewal of ES cells in
vitro.
We recently identified the Oct-3/4-dependent enhancer ele-
ment in the upstream region of the Ebaf/Lefty-1 promoter (N.
Fukui and H. Niwa, unpublished data), confirming that this
gene is one of the direct targets of Oct-3/4. It should be noted,
however, that an ES cell in culture is not experiencing the same
environment as ICM or epiblast cells in the embryo (49). Thus,
it is quite possible that N-TD-specific targets that appear re-
dundant in ES cells might function in vivo at earlier or later
stages of development to induce or maintain stem cell popu-
lations or to direct lineage commitment. Ebaf/Lefty1 encodes a
transforming growth factor beta superfamily protein (38) that
antagonizes the function of activin and nodal and acts as a
midline barrier to establish left-right asymmetry (21, 22). Con-
ceivably, it might act in stem cells to protect them from the
effect of differentiation inducers during development. There-
fore, this class of Oct-3/4 target genes might be particularly
important for ordered differentiation of the epiblast and/or for
maintaining the identity of primordial germ cells during gas-
trulation.
The capacity for integration into the developing embryo and
full developmental repertoire have not been examined in this
study. Unfortunately, the ZHBTc4 system does not lend itself
to such analyses because expression of the variant forms of
Oct-3/4 is under the control of the constitutively active CAG
expression unit and would show unregulated expression after
blastocyst injection. Generation of mice carrying the N or C
deletion introduced by gene targeting is therefore under way to
enable the function of N-TD-dependent target genes to be
determined in vivo.
The rescue effect of the N mutant was weaker than that of
the wild type and C mutant. It might be partly due to the lack
of N-TD-dependent gene expression. In addition, it was re-
FIG. 6. Comparison of gene expression pattern in rescued ES cells.
(A) Expression of Oct-3/4 target genes in ZHBTc4 ES cells and res-
cued ES cells with wild-type, N, or C. Total RNAs prepared from
these ES cells were blotted on nylon membranes, and replicate filters
were analyzed by nonradioactive filter hybridization with the indicated
cDNA probes. Gap was used as a loading control. (B) Expression of
Ebaf/Lefty1 in ES cells rescued by 2–62COct2CTD and 2–
62C1–62 mutant. Sox2 was used as a loading control.
VOL. 22, 2002 Oct-3/4 COMPLEMENTATION ASSAY IN ES CELLS 1533
cently reported that Ets-2-induced transactivation of the tau
interferon promoter is repressed by Oct-3/4 (10). In this case,
full repression required both the N-terminal and POU do-
mains, so the N mutant might have a weaker ability to repress
such trophectoderm-specific genes. However, the repressor
function should not depend completely on the N terminus
because N can rescue ES self-renewal and we could not
detect any ectopic expression of trophectoderm-specific genes
such as Hand-1 and Cdx-2 (29) in the rescued ES cells (data
not shown). It is also possible that the difference between N
and C is based on the slightly different amino acid composi-
tion of N-TD and C-TD. We need to investigate whether
various types of transactivation domains except the proline-
rich type can substitute for the function of transactivation
domains in Oct-3/4 in the future.
Overproduction of Oct-3/4 induces differentiation in ES
cells and possibly also in the nascent hypoblast in vivo (32). We
have proposed that this effect may arise by repression of a
subset of target genes due to sequestration of a particular
cofactor(s) (27, 29). This model is dependent on protein-pro-
tein interactions. In the present study, we found that overex-
pression of the mutant HA267V/P could induce differentiation
even though this amino acid substitution abolishes the DNA-
binding ability of the POU domain. In contrast, overproduc-
tion of the POU domain alone had no effect on stem cell
renewal, although stable production and DNA-binding ability
were confirmed. A fusion of the N and C termini of Oct-3/4
with the Oct-2 POU domain also did not induce differentiation
when overexpressed (data not shown). These data suggest that
the titration out of a relevant partner(s) (41) is achieved by
protein interactions that are independent of DNA binding and
are mediated by both the POU domain and a proline-rich
transactivation domain and that activation of a particular type
of target genes which are repressed in this mechanism should
be important to maintain ES self-renewal (27).
Oct-3/4 uniquely can maintain ES cell self-renewal. Other
POU factors, Oct-1, Oct-2, and Oct-6, that have common
DNA-binding site specificity with Oct-3/4 (37), cannot substi-
tute for it. The data indicate that the presence of a transacti-
vation domain is essential but not specific. Therefore, the sin-
FIG. 7. Transactivation ability of mutant proteins. (A) Oct-3/4-de-
pendent activation of reporter constructs. Luciferase reporter plasmids
carrying various regulatory elements were transfected into ZHBTc4
ES cells in the presence or absence of Tc. The data were calibrated by
both pRL-CMV and PGK-luc, and the ratio for PGK was set at 1.0.
Fgf4-5, Fgf4-3, 6W, 052, and Rex1 showed severalfold-higher ratios,
confirming their Oct-3/4-dependent activation in ES cells. (B) Expres-
sion of luciferase reporters in rescued ES cells. Reporter plasmids
tested in A were transfected into ES cells rescued by wild-type, N, or
C, and their activities were estimated. The data were calibrated by
both pRL-CMV and PGK-luc, and the ratio for PGK was set at 1.0 as
above. Note the lower magnitude of activation of 6W in N than in the
others.
FIG. 8. Episomal expression of various mutants of Oct-3/4 in
MG1.19 ES cells. The bar chart shows the proportion of undifferen-
tiated colonies obtained after supertransfection of episomal vectors for
expression of the indicated mutants and selection for 8 days in puro-
mycin. Supertransfection of Oct-3/4wt and most mutants gave predom-
inantly differentiated colonies. Mutants lacking both transactivation
domains failed to induce significant differentiation.
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gular capacity of Oct-3/4 should be conferred by the POU
domain. Consistent with this, the POU domain is the most
highly conserved region of Oct-3/4 (12). The specific attributes
of the Oct-3/4 POU domain should reside in part at the level
of target sequence selectivity. POU domains consist of a POU
homeodomain (POU-H) and a POU-specific domain (POU-S)
separated by a linker sequence (51). The linker facilitates the
adoption of different conformations on DNA binding and
thereby allows interaction with a range of target sequences (5).
In addition to DNA binding, however, both subdomains of
the POU domain can engage in selective interactions with
different types of proteins. For example, the POU domain of
Oct-1 but not Oct-2 selectively recruits herpes simplex virus
transactivator VP16, and the Oct-1 POU-H is critical for this
specificity (17). Coactivator Bob-1/OCA-B/OBF-1 makes se-
lective contacts with both POU-H and POU-S of Oct-1 and
Oct-2 but does not interact with the POU domains of Oct-3/4,
Oct-6, or Pit-1 (39). Oct-3/4 interactions with adenovirus E1A,
Sox2, and Ets-2 involve the POU domain (10, 41, 57), and
Ambrosetti et al. showed that POU-H plays a critical role in
the formation of a functional Sox2–Oct-3/4 complex (2).
Finally, the POU domain mediates Oct-3/4 dimerization,
which impacts both transcriptional activation and cooperativity
with cofactors (5, 53). The conformation adopted by the POU
domain on binding to a particular DNA sequence leads to
dimerization and/or selective cofactor recruitment, which in
turn may stabilize DNA binding (53). Thus, the emerging pic-
ture of the Oct-3/4 POU domain is as a highly plastic tran-
scriptional organizer. Flexible reciprocal interactions with tar-
get DNA sequences and protein cofactors result in assembly of
gene-specific transcription complexes (3, 5, 26, 57).
Functional analysis of chimeric and mutant POU domains in
the ZHBTc4 complementation system should allow further
refinement of the molecular features that underlie the main-
tenance and propagation of pluripotency and may ultimately
pinpoint a minimal set of key target genes.
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